Negative correlation between early recovery and lipoprotein-associated phospholipase A2 levels after intravenous thrombolysis

J Int Med Res. 2022 Apr;50(4):3000605221093303. doi: 10.1177/03000605221093303.

Abstract

Objective: Lipoprotein-associated phospholipase A2 (Lp-PLA2) is considered a biomarker for systemic inflammation and the risk of myocardial infarction and stroke. However, little is known about the effect of acute vascular events on marker levels. The purpose of this study was to assess the potential association of early recovery with Lp-PLA2 levels in patients with acute ischemic stroke (AIS) after intravenous thrombolysis (IVT).

Methods: Forty-three consecutive AIS patients who had their first stroke and were hospitalized within 5 hours of the onset of stroke were enrolled. All patients were treated with IVT using alteplase or urokinase. Plasma Lp-PLA2 levels were measured within 24 hours after IVT. Variables that showed a significant association with Lp-PLA2 in univariate analysis were included in the multivariate ordered logistic regression model.

Results: Early recovery was associated with Lp-PLA2 levels after IVT, and Lp-PLA2 levels tended to decrease with increased probability of early recovery. This study is the first to report a negative correlation between early recovery and Lp-PLA2 levels after IVT.

Conclusion: Early recovery after IVT was negatively correlated with Lp-PLA2 A2 levels.

Keywords: Acute ischemic stroke; National Institute of Health Stroke Scale; cardiovascular disease; early recanalization; inflammation; intravenous thrombolysis; lipoprotein-associated phospholipase A2.

MeSH terms

  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • Biomarkers
  • Humans
  • Ischemic Stroke*
  • Myocardial Infarction*
  • Risk Factors
  • Stroke* / complications
  • Thrombolytic Therapy

Substances

  • Biomarkers
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase